anti-CD46 mAb (Crucell)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-CD46 mAb (Crucell)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionMembrane cofactor protein inhibitors
TargetsMembrane cofactor protein
Therapy Area/IndicationsColonic NeoplasmsBreast NeoplasmsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCrucell NV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrucell NVJanssen Biotech Inc
Active IndicationsN/A
Inactive IndicationsColonic NeoplasmsBreast NeoplasmsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A